By joining the Emerging Corporate Alliances Program (ECAP), companies gain direct access to world leaders in RNA, LNP and AI—including 2023 Nobel laureate Drew Weissman—through AIRFoundry, the nation’s AI-augmented RNA biofoundry and user facility. AIRFoundry is building the national RNA innovation engine—accelerating discovery, cutting down trial-and-error, and opening new pathways across agriculture, biotech, sustainability, therapeutics, and beyond. AIRFoundry seeks to accelerate the discovery of novel RNA molecules and the development of diverse delivery vehicles, ushering in the “RNA revolution.”
Joining our Emerging Corporate Alliances Program (ECAP) will provide your company with the following access:
- Exclusive monthly briefings on breakthrough discoveries and ongoing projects.
- First access to a highly trained RNA/LNP & AI workforce—future hires who are already trained on state-of-the-art platforms.
- Collaborative forum with peer companies to shape standards, de-risk early R&D, and accelerate translation.
- Direct cost savings on RNA synthesis and LNP formulation services.
We offer three membership tiers for companies:
- End Users/Fast-Track Innovators: leverage AIRFoundry facilities to accelerate your RNA/LNP pipeline, with membership fees credited toward services.
- Technology Integrators/Platform Builders: test and validate your technologies with direct access to AIRFoundry’s user base.
- Talent Seekers/Workforce Catalysts: recruit from the strongest RNA & AI-trained talent pipeline in the nation.
Join ECAP for direct access to the pioneers of RNA technology. To learn more or become a member, contact us at airfoundry [at] seas.upenn.edu or fill out our Contact Form.
